Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (JPY)
Fiscal Period: March 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Pharmaceutical Products

          

Pharmaceutical Operation

963B 1,045B 1,278B 1,602B 1,886B

Total Assets

2,085B 2,221B 2,509B 3,461B 3,456B

Interest Expense

-1.84B -1.94B -2.12B -2.04B -2.13B

Income Tax Expense

-1.71B 6.54B 17.67B 36.22B 59.87B

CAPEX

-64.09B -76.68B -67.37B -88.32B -116B

EBT

74.12B 73.52B 127B 237B 356B

Gross Profit

624B 692B 915B 1,186B 1,470B

D&A

57.38B 58.24B 67.79B 59.65B 68.65B

Operating Income

128B 146B 102B 184B 303B

Net Income

75.96B 66.97B 109B 201B 296B

Geographical Revenue Distribution History

Geographical breakdown of sales (JPY)
Fiscal Period: March 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

United States of America

- - - - 642B

Total Assets

- - - - 291B

Japan

561B 558B 534B 600B 584B

Total Assets

279B 294B 302B 318B 385B

Europe

114B 139B 205B 311B 418B

Total Assets

56.78B 67.34B 85.34B 131B 152B

Other Regions

96.09B 112B 144B 192B 242B

Total Assets

8.13B 10B 7.58B 12.25B 13.79B

North America

192B 236B 397B 499B -

Total Assets

172B 180B 212B 237B -